Sangamo Therapeutics
SGMO
SGMO
203 hedge funds and large institutions have $994M invested in Sangamo Therapeutics in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 65 increasing their positions, 72 reducing their positions, and 38 closing their positions.
Holders
203
Holders Change
-19
Holders Change %
-8.56%
% of All Funds
3.58%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
65
Reduced
72
Closed
38
Calls
$18.7M
Puts
$12M
Net Calls
+$6.66M
Net Calls Change
-$11.5M
Top Buyers
Top Sellers
1 |
1
UBS AM
Chicago,
Illinois
|
$1.27M |
2 |
2
Voloridge Investment Management
Jupiter,
Florida
|
$0 |
3 |
3
Goldman Sachs
New York
|
$24.2M |
4 |
CC
4
Casdin Capital
New York
|
$6.89M |
5 |
5
Renaissance Technologies
New York
|
$9.77M |